Ingrid Baar

Dr. Ingrid Baar


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2024 in Life
Verified
Journal Article
Open access
PDF file
RJRita Jacobs
Rita Jacobs
WVWalter Verbrugghe
Walter Verbrugghe
JBJason Bouziotis
Jason Bouziotis
IBIngrid Baar
Ingrid Baar
KDKarolien Dams
Karolien Dams
PJPhilippe G. Jorens
Philippe G. Jorens
(1) Background: Citrate is preferred in continuous renal replacement therapy (CRRT) for critically ill patients because it prolongs filter life and reduces bleeding risks compared to unfractionated heparin (UFH). However, regional citrate anticoagulation (RCA) can lead to acid–base disturbances, citrate accumulation, and overload. This study compares the safety and efficacy of citrate-based CRRT with UFH and no anticoagulation (NA) in acute kidney injury (AKI) patients. (2) Methods: A retrospective analysis was conducted on adult patients (≥18 years) who underwent CRRT from July 2010 to June 2021 in an intensive care unit. (3) Results: Among 829 AKI patients on CRRT: 552 received RCA, 232 UFH, and 45 NA. The RCA group had a longer filter lifespan compared to UFH and NA (56 h [IQR, 24–110] vs. 36.0 h [IQR, 17–63.5] vs. 22 h [IQR, 12–48]; all Padj < 0.001). Bleeding complications were fewer in the RCA group than in the UFH group (median 3 units [IQR, 2–7 units] vs. median 5 units [IQR, 2–12 units]; Padj < 0.001) and fewer in the NA group than in the UFH group (median 3 units [IQR, 1–5 units] vs. 5 units [IQR, 2–12 units]; Padj = 0.03). Metabolic alkalosis was more common in the RCA group (32.5%) compared to the UFH (16.2%) and NA (13.5%) groups, while metabolic acidosis persisted more in the UFH group and NA group (29.1% and 34.6%) by the end of therapy vs. the citrate group (16.8%). ICU mortality was lower in the RCA group (52.7%) compared to the UFH group (63.4%; Padj = 0.02) and NA group (77.8%; Padj = 0.003). (4) Conclusions: Citrate anticoagulation outperforms heparin-based and no anticoagulation in filter patency, potentially leading to better outcomes through improved therapy effectiveness and reduced transfusion needs. However, careful monitoring is crucial to limit potential complications attributable to its use.

17 May 2019
Verified
Conference Paper
Closed access
HJHelena Janssen
Helena Janssen
PVPeter Vanacker
Peter Vanacker
SNStefania Nannoni
Stefania Nannoni
OFOlivier Francois
Olivier Francois
TDTom Dewaele
Tom Dewaele
HPHans Pottel
Hans Pottel
Introduction: Futile recanalization, defined as lack of clinical benefit despite angiographic recanalization, is an important limitation of endovascular treatment for acute ischemic stroke (AIS). Data on this topic in nonagenarians, who are increasingly being admitted to our hospitals, is scarce. Material & Methods: Retrospective observational study with data collection from